Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
The candidate will develop and benchmark zero-shot multimodal fusion models for rare disease prediction, using melanoma as a use case. The project integrates spatial and single-cell multi-omics data with
-
Belgium (BE, 2 months). Special requirements: In accordance with the Marie Skłodowska-Curie Actions Doctoral Network regulations: Applicants must comply with the MSCA Mobility Rule. At the time of
-
.•Experience in designing and troubleshooting experiments is a plus.•Experience with or knowledge of single-cell and/or spatial (multi-)omics methods is a plus. •Applicants must be doctoral candidates, i.e not
-
shortlisted applicants are scheduled between 12 and 23 October. Shortlisted applicants will be notified by 6 October. At this point, shortlisted candidates will be asked to prepare a research proposal of some 4
-
novel research initiatives. You will gain in-depth knowledge of gene therapy research and the associated development process. Additionally, you will be exposed to (single-cell) transcriptomics techniques
-
asked to prepare a research proposal of some 4 pages in preparation of the interview. The start date will be determined in consultation with the successful applicant, taking into account any necessary
-
will be asked to prepare a research proposal of some 4 pages in preparation of the interview. The start date will be determined in consultation with the successful applicant, taking into account any
-
. This project explores the use of laser-printed metal chalcogenides on flexible substrates to develop high-performance thermoelectric harvesters and coolers for wearable applications. In this project, the postdoc
-
‑situ digital working instructions (DWIs). However, current AR/VR solutions are typically developed as standalone applications, manually authored, and weakly connected to product‑level data. As a result
-
. The research has two closely linked objectives: 1. Development of an integrated spatial multi-omics workflow for simultaneous transcriptome, proteome, and lipidome profiling. 2. Application of the workflow